Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 5
2004 3
2005 2
2007 1
2008 1
2009 3
2010 6
2011 3
2012 2
2013 2
2014 4
2015 5
2016 2
2017 4
2018 4
2019 4
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

47 results
Results by year
Filters applied: . Clear all
Page 1
Future Approaches to Precision Oncology-Based Clinical Trials.
Mittra A, Moscow JA. Mittra A, et al. Among authors: moscow ja. Cancer J. 2019 Jul/Aug;25(4):300-304. doi: 10.1097/PPO.0000000000000383. Cancer J. 2019. PMID: 31335395 Review.
The evidence framework for precision cancer medicine.
Moscow JA, Fojo T, Schilsky RL. Moscow JA, et al. Nat Rev Clin Oncol. 2018 Mar;15(3):183-192. doi: 10.1038/nrclinonc.2017.186. Epub 2017 Dec 19. Nat Rev Clin Oncol. 2018. PMID: 29255239 Review.
Steps forward for cancer precision medicine.
Salgado R, Moore H, Martens JWM, Lively T, Malik S, McDermott U, Michiels S, Moscow JA, Tejpar S, McKee T, Lacombe D; IBCD-Faculty. Salgado R, et al. Among authors: moscow ja. Nat Rev Drug Discov. 2018 Jan;17(1):1-2. doi: 10.1038/nrd.2017.218. Epub 2017 Nov 24. Nat Rev Drug Discov. 2018. PMID: 29170471
Phase II trial of the glycoprotein non-metastatic B-targeted antibody-drug conjugate, glembatumumab vedotin (CDX-011), in recurrent osteosarcoma AOST1521: A report from the Children's Oncology Group.
Kopp LM, Malempati S, Krailo M, Gao Y, Buxton A, Weigel BJ, Hawthorne T, Crowley E, Moscow JA, Reid JM, Villalobos V, Randall RL, Gorlick R, Janeway KA. Kopp LM, et al. Among authors: moscow ja. Eur J Cancer. 2019 Nov;121:177-183. doi: 10.1016/j.ejca.2019.08.015. Epub 2019 Oct 3. Eur J Cancer. 2019. PMID: 31586757 Free PMC article. Clinical Trial.
Distinguishing mechanisms of adverse drug reactions from mechanisms of actions of drugs.
Wu TH, Karim N, Moscow JA. Wu TH, et al. Among authors: moscow ja. Oncotarget. 2018 Aug 21;9(65):32404-32405. doi: 10.18632/oncotarget.25968. eCollection 2018 Aug 21. Oncotarget. 2018. PMID: 30197750 Free PMC article. No abstract available.
Societal challenges of precision medicine: Bringing order to chaos.
Salgado R, Moore H, Martens JWM, Lively T, Malik S, McDermott U, Michiels S, Moscow JA, Tejpar S, McKee T, Lacombe D; IBCD-Faculty. Salgado R, et al. Among authors: moscow ja. Eur J Cancer. 2017 Oct;84:325-334. doi: 10.1016/j.ejca.2017.07.028. Epub 2017 Sep 4. Eur J Cancer. 2017. PMID: 28865260
A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatment.
Lim B, Murthy RK, Lee J, Jackson SA, Iwase T, Davis DW, Willey JS, Wu J, Shen Y, Tripathy D, Alvarez R, Ibrahim NK, Brewster AM, Barcenas CH, Brown PH, Giordano SH, Moulder SL, Booser DJ, Moscow JA, Piekarz R, Valero V, Ueno NT. Lim B, et al. Among authors: moscow ja. Br J Cancer. 2019 Jun;120(12):1105-1112. doi: 10.1038/s41416-019-0473-y. Epub 2019 May 17. Br J Cancer. 2019. PMID: 31097774 Free PMC article. Clinical Trial.
Transforming the Early Drug Development Paradigm at the National Cancer Institute: The Formation of NCI's Experimental Therapeutics Clinical Trials Network (ETCTN).
Massett HA, Mishkin G, Moscow JA, Gravell A, Steketee M, Kruhm M, Han SH, Barry B, Montello M, Zwiebel J, Abrams JS, Doroshow JH, Ivy SP. Massett HA, et al. Among authors: moscow ja. Clin Cancer Res. 2019 Dec 1;25(23):6925-6931. doi: 10.1158/1078-0432.CCR-19-1754. Epub 2019 Aug 22. Clin Cancer Res. 2019. PMID: 31439585 Free PMC article.
Chemo brain (chemo fog) as a potential side effect of doxorubicin administration: role of cytokine-induced, oxidative/nitrosative stress in cognitive dysfunction.
Aluise CD, Sultana R, Tangpong J, Vore M, St Clair D, Moscow JA, Butterfield DA. Aluise CD, et al. Among authors: moscow ja. Adv Exp Med Biol. 2010;678:147-56. doi: 10.1007/978-1-4419-6306-2_19. Adv Exp Med Biol. 2010. PMID: 20738017 Review.
Novel role of 4-hydroxy-2-nonenal in AIFm2-mediated mitochondrial stress signaling.
Miriyala S, Thippakorn C, Chaiswing L, Xu Y, Noel T, Tovmasyan A, Batinic-Haberle I, Vander Kooi CW, Chi W, Latif AA, Panchatcharam M, Prachayasittikul V, Butterfield DA, Vore M, Moscow J, St Clair DK. Miriyala S, et al. Among authors: moscow j. Free Radic Biol Med. 2016 Feb;91:68-80. doi: 10.1016/j.freeradbiomed.2015.12.002. Epub 2015 Dec 9. Free Radic Biol Med. 2016. PMID: 26689472 Free PMC article.
47 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback